ISIN
FR0011005933
Ticker
ALBIO
Sector
Sub-Industry
Country
France
Year Founded
2005
Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid tests (RDT). Biosynex is now the French market leader in this field.
Fast and easy to use, these tests are commercialized in France and in some 90 countries through local distributors. By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.
Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR).
248
Worldwide
FR0011005933
969500H4BGE1HBLGP566
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.